The chip offers intracellular and extracellular recording, voltage- and current-controlled stimulation, impedance monitoring and spectroscopy functionalities. It has the most cell-interfacing modalities on a single chip and is the only one to enable multi-well assays.
According to imec the chip has created a platform that enables high quality data acquisition at increased throughput in cell-based cell studies.
MEAs have long been used for in vitro cell-interaction experiments but most MEAs do not support high throughput measurements, making current cell-assays time-consuming. Typically passive devices, without built-in circuitry, they require complex external equipment for data acquisition. In addition, most MEAs are not able to accommodate the extra sensing modalities to fully characterise complex cell behaviour and interactions.
Imec’s CMOS-MEA has been able to pack 16,384 active electrodes with signal processing, filtering and analogue-to-digital conversion on-chip, resulting in a compact system with easy interfacing. Each electrode has a miniature pre-amplifier to improve the signal quality.
The electrodes are grouped in 16 clusters, each of which can be addressed individually, making it possible to run 16 experiments independently and simultaneously.
This CMOS-MEA also includes 1,024 low-noise readout channels that can be connected to any of the 16,384 electrodes. The custom reconfigurable on-chip circuits support 6 cell-interfacing modalities: both extra- and intracellular electrical activity recording, constant voltage and constant current stimulation for cell excitation or localized electroporation, fast impedance monitoring and, finally, impedance spectroscopy.
While fast impedance monitoring can detect impedance changes over time and cell presence for optimal electrode selection, single-cell impedance spectroscopy gives detailed information of the electrode impedance, seal resistance and cell-membrane impedance which can be used for cell differentiation.
Imec’s high input impedance, low noise and low power reconfigurable circuits make it possible to integrate 1,024 parallel readout channels and 64 reconfigurable stimulation units on a small chip area.
“Not only are we reporting the highest number of modalities so far on a single chip with a very high channel count, we are able to achieve this without any performance penalty. Moreover, by offering six modalities on such large scale, the imec CMOS-MEA will greatly improve the throughput and versatility of cell-based assays,” commented Nick Van Helleputte, manager biomedical circuits at imec. “With the introduction of CMOS chip technology into the MEA-technology, we have realized a breakthrough in cell interfacing.”
Imec’s micro-electrode array chip will be presented at ISSCC in San Francisco.
